Dr. Yoo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1300 N Highland Ave Ste 1
Aurora, IL 60506Phone+1 630-897-5104Fax+1 630-897-5089
Education & Training
Henry Ford HospitalFellowship, Ophthalmic Plastic and Reconstructive Surgery, 2005 - 2006
McGaw Medical Center of Northwestern UniversityResidency, Ophthalmology, 2002 - 2005- McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 2001 - 2002
- Northwestern University The Feinberg School of MedicineClass of 2001
Certifications & Licensure
IL State Medical License 1996 - 2026
MI State Medical License 2005 - 2009- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- 33 citationsManagement of ocular conditions in the burn unit: thermal and chemical burns and Stevens-Johnson syndrome/toxic epidermal necrolysis.Amy Lin, Neha Patel, David Yoo, Sheri DeMartelaere, Charles S. Bouchard
Journal of Burn Care & Research. 2011-09-01 - 6 citationsCemiplimab for Orbital Squamous Cell Carcinoma in 11 Cases.Benjamin Steren, Barbara Burtness, Aarti Bhatia, Hakan Demirci, Roman Shinder
Ophthalmic Plastic and Reconstructive Surgery. 2022-05-03 - 8 citationsA novel telemedicine technique for evaluation of ocular exam findings via smartphone images.Joshua Sink, Stephen Blatt, David Yoo, Michael Francis Henry, S Daniel Yang
Journal of Telemedicine and Telecare. 2020-06-06
Journal Articles
- Myoepithelioma of the Orbital Apex and Middle Cranial Fossa: Case Report and Review of the LiteratureHayward DM, Yoo D, Lee JM, Wild E, Prabhu VC, Neuro-Ophthalmology, 2/2014
Press Mentions
Horizon’s Eye Drug Teprotumumab Wins FDA Panel Backing in Unanimous VoteDecember 13th, 2019
Professional Memberships
- Fellow
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
